Skip to the content Skip to the main menu
ShroomStocks.ca

Investing is a trip

  • Featured Content
  • Mushrooms
  • Psychedelics
  • Psilocybin
  • Microdosing
  • Media

Top Posts & Pages

  • We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
    We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
  • Yield Growth (BOSS.C) files a patent for mushrooms as weight loss, and begins tasting trials
    Yield Growth (BOSS.C) files a patent for mushrooms as weight loss, and begins tasting trials
  • Cybin (CYBN.N) finishes its first trading day on the NYSE
    Cybin (CYBN.N) finishes its first trading day on the NYSE
  • Absolem Health signs a mushroom extraction deal
    Absolem Health signs a mushroom extraction deal
  • Tryp Therapeutics (TRYP.C) announces plans for TRYP-8802 Phase 2a study on fibromyalgia
    Tryp Therapeutics (TRYP.C) announces plans for TRYP-8802 Phase 2a study on fibromyalgia

Recent Posts

  • Filament Health (FH.NEO) applies to the OTC boards and the Depository Trust Company
  • Filament Health (FH.NEO) expands on their intellectual property portfolio with 20th patent application
  • Merger between Red Light Holland (TRIP.C) and Creso Pharma (CPH.ASX) merger falls through due to COVID-19 complications
  • Filament Health (FH.NE) goes transnational with first psilocybin export to the United States
  • Braxia (BRAX.C) announces first multi-dose psilocybin trial in Canada
  • Psychedelic Weekly Roundup with MNMD.Q, MSET.C, MYND.C, MEDI.NE, AWKN.NE, SILO, MCUR.C, NOVA.C, TRYP.C, TPIA, NEON.C
  • Awakn (AWKN.NE) receives ethical approval to treat gambling addiction with ketamine
  • Mindset (MSET.C) files second patent on DMT and 5-MeO-DMT analogs
  • MindMed (MNMD.Q) partners with Forian, bringing data analysis to their psychedelic clinical trials
  • Novamind (NM.C) – Investor Roundtable
  • Novamind (NM.CN) Potential Bottom? But I Would Rather Play PSYK.NE.
  • Weekly Psychedelic Roundup: Lots of patents, lots of financials
  • About

Investing is a trip

  • Home
  • Posts

Top Posts & Pages

  • We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
    We downloaded RLOVE, a dating app for psychonauts and "light warriors." Here's what happened
  • Yield Growth (BOSS.C) files a patent for mushrooms as weight loss, and begins tasting trials
    Yield Growth (BOSS.C) files a patent for mushrooms as weight loss, and begins tasting trials
  • Cybin (CYBN.N) finishes its first trading day on the NYSE
    Cybin (CYBN.N) finishes its first trading day on the NYSE
  • Absolem Health signs a mushroom extraction deal
    Absolem Health signs a mushroom extraction deal
  • Tryp Therapeutics (TRYP.C) announces plans for TRYP-8802 Phase 2a study on fibromyalgia
    Tryp Therapeutics (TRYP.C) announces plans for TRYP-8802 Phase 2a study on fibromyalgia

Recent Posts

  • Filament Health (FH.NEO) applies to the OTC boards and the Depository Trust Company
  • Filament Health (FH.NEO) expands on their intellectual property portfolio with 20th patent application
  • Merger between Red Light Holland (TRIP.C) and Creso Pharma (CPH.ASX) merger falls through due to COVID-19 complications
  • Filament Health (FH.NE) goes transnational with first psilocybin export to the United States
  • Braxia (BRAX.C) announces first multi-dose psilocybin trial in Canada
  • Psychedelic Weekly Roundup with MNMD.Q, MSET.C, MYND.C, MEDI.NE, AWKN.NE, SILO, MCUR.C, NOVA.C, TRYP.C, TPIA, NEON.C
  • Awakn (AWKN.NE) receives ethical approval to treat gambling addiction with ketamine
  • Mindset (MSET.C) files second patent on DMT and 5-MeO-DMT analogs
  • MindMed (MNMD.Q) partners with Forian, bringing data analysis to their psychedelic clinical trials
  • Novamind (NM.C) – Investor Roundtable
  • Novamind (NM.CN) Potential Bottom? But I Would Rather Play PSYK.NE.
  • Weekly Psychedelic Roundup: Lots of patents, lots of financials
  • About
Fallback image

Filament Health (FH.NEO) applies to the OTC boards and the Depository Trust Company

  • Post date
    September 7, 2021
  • Posted by
    Joseph
  • Posted in Depository Trust Company, DTC, FH.NE, FH.NEO, Filament Health, Mushrooms, OTC markets, OTCQX Best Market, Psychedelics
  • Comments
    0
Fallback image

Filament Health (FH.NEO) expands on their intellectual property portfolio with 20th patent application

  • Post date
    September 2, 2021
  • Posted by
    Joseph
  • Posted in drug discovery, extraction technologies, FH.NE, Filament Health, intellectual property, Morton, patents, psilocybin, Psychedelics
  • Comments
    0
Fallback image

Merger between Red Light Holland (TRIP.C) and Creso Pharma (CPH.ASX) merger falls through due to COVID-19 complications

  • Post date
    August 30, 2021
  • Posted by
    Joseph
  • Posted in bruce linton red light holland, Cannabis, CPH.ASX, Creso Pharma, magic truffles, Mushrooms, Psychedelics
  • Comments
    0
Fallback image

Filament Health (FH.NE) goes transnational with first psilocybin export to the United States

  • Post date
    August 27, 2021
  • Posted by
    Joseph
  • Posted in Drug Enforcement Administration, FH.NE, Filament Health, Morton, Mushrooms, psilcoybin, Psychedelics
  • Comments
    0
Fallback image

Braxia (BRAX.C) announces first multi-dose psilocybin trial in Canada

  • Post date
    August 27, 2021
  • Posted by
    Piers Eaton
  • Posted in brax.c, braxia, braxia scientific, CRTCE, Multi-Dose, Mushrooms, psilocybin, Psychedelics
  • Comments
    0

Nothing more to load.

Next Page →

Theme by Anders Norén